Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Accumulated Expenses (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Accumulated Expenses for 16 consecutive years, with $18.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 12598.61% to $18.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.3 million, a 12598.61% increase, with the full-year FY2025 number at $18.3 million, up 12598.61% from a year prior.
  • Accumulated Expenses was $18.3 million for Q4 2025 at Lemaitre Vascular, up from $16.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $18.3 million in Q4 2025 to a low of $144000.0 in Q4 2024.
  • A 5-year average of $8.8 million and a median of $8.2 million in 2021 define the central range for Accumulated Expenses.
  • Biggest YoY gain for Accumulated Expenses was 12598.61% in 2025; the steepest drop was 84.27% in 2025.
  • Lemaitre Vascular's Accumulated Expenses stood at $16.3 million in 2021, then tumbled by 34.06% to $10.8 million in 2022, then crashed by 65.74% to $3.7 million in 2023, then plummeted by 96.1% to $144000.0 in 2024, then skyrocketed by 12598.61% to $18.3 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Accumulated Expenses are $18.3 million (Q4 2025), $16.2 million (Q3 2025), and $2.4 million (Q2 2025).